Dr Reddy’s Laboratories ( (RDY) ) has shared an announcement.
On March 12, 2025, Dr. Reddy’s Laboratories announced its participation in an investor conference organized by Bank of America, scheduled for March 19, 2025, in New York. This in-person group meeting is part of the company’s efforts to engage with institutional investors and analysts, potentially impacting its market positioning and stakeholder relations.
More about Dr Reddy’s Laboratories
Dr. Reddy’s Laboratories is a prominent player in the pharmaceutical industry, focusing on the development and production of generic medications, active pharmaceutical ingredients, and over-the-counter products. The company is headquartered in Hyderabad, India, and is known for its commitment to providing affordable and innovative medicines globally.
YTD Price Performance: -18.89%
Average Trading Volume: 1,832,195
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $10.68B
Find detailed analytics on RDY stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com